Sort
48,018 grants matching “immunotherapy”
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$552,535Deborah W Knapp · Purdue University · U01 · FY2023 · CA
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer
$552,526Kenneth P Olive · Columbia University Health Sciences · R01 · FY2024 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$552,495Philip D Greenberg · University Of Washington · R01 · FY2013 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$552,488Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
THERAPEUTIC MANUFACTURING
$552,471Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2012 · CA
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$552,383Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$552,336Vincent J Hearing · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$552,266Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Integrated Discovery Pipeline for Tumor Neoantigens
$552,250Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2018 · CA
Small circular mRNA vaccines
$552,247Guizhi Zhu · Virginia Commonwealth University · R01 · FY2023 · AI
Small circular mRNA vaccines
$552,247Guizhi Zhu · Virginia Commonwealth University · R01 · FY2022 · AI
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$552,182Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
NIH Chronic GVHD Study Group
$552,181Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
$552,176Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2020 · CA
Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
$552,176Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2019 · CA
Novel Computation Methods for the Analysis of Cell-Free DNA Sequence Data
$552,176Xianghong Jasmine Zhou · University Of California Los Angeles · R01 · FY2021 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
$552,171Steven W. Dow · Colorado State University · U01 · FY2022 · CA
A deubiquitination module controls Treg adaptation to tumor microenvironment
$552,115Deyu Fang · Northwestern University At Chicago · R01 · FY2023 · CA
Project 2: Radiation-Induced Lymphopenia: Understanding, Predictive Modeling and Developing Photon and Proton-Based Mitigation Strategies.
$552,100Steven Hsesheng Lin · Massachusetts General Hospital · P01 · FY2022 · CA
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
$552,054Giannicola Genovese · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$551,987David G Denardo · Washington University · R01 · FY2021 · CA
ITIM-receptors for cancer treatment
$551,973Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$551,927Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Modulation of the tumor microenvironment with probiotic therapies
$551,862Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · CA
Congenic Mouse Medels of Melanoma for the Characterization of Tumor Immune Responses
$551,750Marcus W Bosenberg · Yale University · R01 · FY2017 · CA